Sage Journals: Discover world-class research

Abstract

Background

Renal surface nodularity (RSN) is a subclinical biomarker of renal injury and may be associated with arterial hypertension.

Purpose

To explore the association of RSN with arterial hypertension compared to normotensive patients.

Material and Methods

A total of 205 inpatients with or without high blood pressure (HBP vs. control group) who underwent abdominal computed tomography (CT) scans were included. Their clinical characteristics included age, sex, HBP course, HBP grade, history of diabetes mellitus (DM), and renal function (estimated glomerular filtration rate [eGFR]). The HBP group included HBP/+DM and HBP/–DM based on the presence or absence of DM. The CT-based RSN grade was scored from 0 to 2 by two radiologists, respectively, where RSN grade 0 indicated smooth renal surface, grade 1 was mild RSN, and grade 2 was marked RSN.

Results

The inter-rater agreement on RSN was good (Kappa = 0.76). The age-specific rate of RSN grade 1–2 was bigger in the HBP group than in the control group (42.86% [40%–49.22%] vs. 2.18% [0.00%–22.5%]; P = 0.005). RSN grade was associated with HBP course (P < 0.02). The rates of RSN grade 1–2 and of RSN grade 2 were bigger in the HBP/+DM group than those in the HBP/–DM group (48.84% vs. 37.84%, and 18.61% vs. 1.35%, respectively; all P = 0.001). Neither HBP course nor HBP grade correlated with rate of RSN grade (P > 0.05). The eGFR was similar among the RSN grades in HBP or between the HBP and control groups (P > 0.05).

Conclusion

RSN was associated with HBP compared to normotensive patients.

Keywords

Renal surface nodularity hypertension renal function tomography

Get full access to this article

View all access options for this article.

References

NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 2021;398:957–980.

Nwoha

Okoro

Nwoha

, et al. Sex, knowledge, and attitude of stroke survivors attending Bebe herbal center on risk factors before and after stroke. Stroke Res Treat 2021;2021:6695522.

Zhou

Perel

Mensah

, et al. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol 2021;28:785–802.

Mule

Castiglia

Cusumano

, et al. Subclinical kidney damage in hypertensive patients: a renal window opened on the cardiovascular system. Focus on microalbuminuria. Adv Exp Med Biol 2017;956:279–306.

Kawada

. Blood pressure control in hypertensive patients with chronic kidney disease. J Hypertens 2017;35:1327–1328.

Bilo

Parati

. Blood pressure variability and kidney disease: another vicious circle? J Hypertens 2018;36:1019–1021.

Denic

Alexander

Kaushik

, et al. Detection and clinical patterns of nephron hypertrophy and nephrosclerosis among apparently healthy adults. Am J Kidney Dis 2016;68:58–67.

Duan

Rule

Elsherbiny

, et al. Automated assessment of renal cortical surface roughness from computerized tomography images and its association with age. Acad Radiol 2014;21:1441–1445.

Scott

Scuffham

Gupta

, et al. Going digital: a narrative overview of the effects, quality and utility of mobile apps in chronic disease self-management. Aust Health Rev 2020;44:62–82.

10.

Levey

Stevens

Schmid

, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604–612.

11.

James

Oparil

Carter

, et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8). JAMA 2014;2014:507–520.

12.

American Diabetes Association . Diagnosis and classification of diabetes mellitus. Diabetes Care 2013;36:S67–S74.

13.

Samuel

Hoy

Douglas-Denton

, et al. Determinants of glomerular volume in different cortical zones of the human kidney. J Am Soc Nephrol 2005;16:3102–3109.

14.

Wang

do Carmo

Aberdein

, et al. Synergistic interaction of hypertension and diabetes in promoting kidney injury and the role of endoplasmic reticulum stress. Hypertension 2017;69:879–891.

15.

Hesp

Schaub

Prasad

, et al.

The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors?

Kidney Int 2020;98:579–589.

16.

Denic

Lieske

Chakkera

, et al. The substantial loss of nephrons in healthy human kidneys with aging. J Am Soc Nephrol 2017;28:313–320.

17.

Choudhury

Levi

. Kidney aging--inevitable or preventable? Nat Rev Nephrol 2011;7:706–717.

18.

De Rosa

Samoni

Ronco

. Creatinine-based definitions: from baseline creatinine to serum creatinine adjustment in intensive care. Crit Care 2016;20:69.

19.

Smith

. Pyelonephritis, renal scarring, and reflux nephropathy: a pediatric urologist’s perspective. Pediatr Radiol 2008;38:S76–S82.

20.

Maeda

Yoshimura

Takahashi

, et al. Usefulness of the blood pressure classification in the new 2017 ACC/AHA hypertension guidelines for the prediction of new-onset chronic kidney disease. J Hum Hypertens 2019;33:873–878.

21.

Aoki

Kai

Kajimoto

, et al. Large blood pressure variability aggravates arteriolosclerosis and cortical sclerotic changes in the kidney in hypertensive rats. Circ J 2014;78:2284–2291.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.11 MB

Association of renal surface nodularity with arterial hypertension compared to normotensive patients